Dr. David Brooks is Senior Director, Business Licensing at Johnson and Johnson in Radnor, PA.  During the course of his career he has been at the forefront of identifying and managing innovation as an experienced and accomplished pharmaceutical executive and scientist.  His recent roles at J&J have been in scientific licensing as well as establishing external drug discovery initiatives with universities and biotechnology firms.  Prior to joining J&J, Dr. Brooks was at GlaxoSmithKline Pharmaceuticals where he was Vice President of Biology responsible for up to 70 scientists in the cardiovascular and urogenital discovery departments.  He began his career with research and teaching positions at the University of Tennessee.  Dr. Brooks holds a Ph.D. in Physiology and an M.Sc.in  Biochemical Pharmacology, both from Southampton University, UK, and a B.Sc. (Hons), in Physiology and Chemistry, QEC, from the University of London, UK.  He is a Fellow of the American Heart Association, an Honorary Professor at Warwick Medical School, UK and has over 200 publications.

Dr. Michael Christman has been President and CEO of the non-profit Coriell Institute for Medical Research since 2007. He initiated the Coriell Personalized Medicine Collaborative (CPMC), a project that has put Coriell at the forefront of genome-informed medicine. The CPMC is a research study with the goal of determining the utility of using genome information in health management and clinical decision-making using an evidence-based approach.  The CPMC study was cited in a November 2008 Nature magazine commentary as “leading by example” in understanding how personal genome information will be used by individuals and their physicians.  Prior to coming to Coriell he chaired the Department of Genetics and Genomics at Boston University School of Medicine and led an international group that performed one of the first genome-wide association studies, using the Framingham Heart Study Cohort.   Dr. Christman received his B.S. in Chemistry with honors from the University of North Carolina at Chapel Hill, his Ph.D. in Biochemistry from the University of California at Berkeley and did post-doctoral work in genetics at the Massachusetts Institute of Technology (MIT).

Richard K. Schatzberg is the Co-Founder, President and CEO of Generation Health Inc., a startup that provides personalized medicine services to employers who are highly motivated to bring about improved health outcomes and lower prescription costs.  In his current position he plays an influential role in the current discussion about genetic information becoming a key consideration in making treatment decisions.  He is a veteran of the pharmacy benefit management business, with a 20-year career with Medco Health Solutions involving a number of executive leadership responsibilities.  He has also served as EVP at Merck-Medco, as well as member of the Board of Directors at RelayHealth.

Tom Spann is the CEO of Accolade, LLC, a built-for-purpose business which works with large enterprise clients to increase the value of healthcare benefits for their employees.  Before taking the lead at Accolade, he was Senior Managing Partner at Accenture where he led the North America Products Group, a $2 billion+ revenue, 10,000 employee operating unit that served clients in the Life Sciences sector as well as other industries.  Prior to that role, Tom led the Health & Life Sciences operating unit through a period of rapid growth. Tom also led the Pharmaceutical and Medical Products practice, was President of the Accenture Foundation, and served on Accenture’s CEO and Board Nominating Committees during his 26-year career there.  In his tenure at Accenture, Tom specialized in shaping and leading large-scale enterprise change programs. He played a significant leadership role in several pharmaceutical industry start-ups, most notably Astra-Merck where he led the Accenture relationship that helped this client grow from a one-employee joint venture to today’s AstraZeneca in the U.S.  Tom holds a B.S. in Economics from the Wharton School of the University of Pennsylvania.